Erratum: Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents (Journal of Medicinal Chemistry (2011) 54 (8110-8123) DOI:10.1021/jm200946h);Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents

Journal of Medicinal Chemistry

Volumn 54, Issue 23, 2011, Pages 8110-8123

  Wu, Jianzhang ^a,b   Li, Jianling ^a   Cai, Yuepiao ^a   Pan, Yong ^a   Ye, Faqing ^a   Zhang, Yali ^b   Zhao, Yunjie ^a   Yang, Shulin ^b   Li, Xiaokun ^a   Liang, Guang ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO 4' METHOXYCHALCONE; 2 CHLORO 4' AMINOCHALCONE; 2 CHLORO 4' METHOXYCHALCONE; 2 FLUORO 4' METHOXYCHALCONE; 2 METHOXY 4' AMINOCHALCONE; 2 TRIFLUOROMETHYL 4' AMINOCHALCONE; 2 TRIFLUOROMETHYLCHALCONE; 2,3 DIMETHOXY 3' AMINOCHALCONE; 2,3 DIMETHOXY 4' METHOXYCHALCONE; 2,3 DIMETHOXYPHENYL 4' AMINOCHALCONE; 2,3',4,4',5' PENTAMETHOXYCHALCONE; 2,4 DICHLORO 2' HYDROXYCHALCONE; 2,4 DICHLORO 4' METHOXYCHALCONE; 2,4 DIMETHOXY 2' HYDROXYCHALCONE; 2,4 DIMETHOXY 3',4' DIFLUOROCHALCONE; 2,4 DIMETHOXY 4' AMINOCHALCONE; 2,4 DIMETHOXYPHENYLCHALCONE; 2,4,4',6 TETRAMETHOXYCHALCONE; 2,4,6 TRIMETHOXY 2' HYDROXYCHALCONE; 3,4 DICHLORO 4' METHOXYCHALCONE; 4 (DIMETHYLAMINO) 4' AMINOCHALCONE; 4 (DIMETHYLAMINO)CHALCONE; 4 DIMETHYLAMINO 3' AMINOCHALCONE; 4 DIMETHYLAMINO 4' METHOXYCHALCONE; 4 HYDROXY 4' METHOXYCHALCONE; 4 METHOXY 3' AMINOCHALCONE; 4 METHOXY 4' AMINOCHALCONE; ANTIINFLAMMATORY AGENT; CHALCONE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG SCREENING; ENZYME ACTIVATION; ENZYME INHIBITION; MACROPHAGE; MALE; MORTALITY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 82555187401     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401141q     Document Type: Erratum

References (41)

1. Atreya, R.; Mudter, J.; Finotto, S.; Müllberg, J.; Jostock, T.; Wirtz, S.; Schütz, M.; Bartsch, B.; Holtmann, M.; Becker, C. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo Nat. Med. 2000, 6, 583-588
2. Kalogeropoulos, A.; Georgiopoulou, V.; Psaty, B.; Rodondi, N.; Smith, A.; Harrison, D.; Liu, Y.; Hoffmann, U.; Bauer, D.; Newman, A. Inflammatory markers and incident heart failure risk in older adults the health ABC (health, aging, and body composition) study J. Am. Coll. Cardiol. 2010, 55, 2129-2137
3. Ait-Oufella, H.; Taleb, S.; Mallat, Z.; Tedgui, A. Recent advances on the role of cytokines in atherosclerosis Arterioscler., Thromb., Vasc. Biol. 2011, 31, 969-979
4. McInnes, I.; Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis Nat. Rev. Immunol. 2007, 7, 429-442
5. Grivennikov, S. I.; Karin, M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage Ann. Rheum. Dis. 2011, 70 (Suppl. 1) i104-i108
6. Qiu, Y.; Yanase, T.; Hu, H.; Tanaka, T.; Nishi, Y.; Liu, M.; Sueishi, K.; Sawamura, T.; Nawata, H. Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development Endocrinology 2010, 151, 3307-3316
7. Mazor, R.; Itzhaki, O.; Sela, S.; Yagil, Y.; Cohen-Mazor, M.; Yagil, C.; Kristal, B. Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension Hypertension 2010, 55, 353-362
8. Duffield, J. S. Macrophages and immunologic inflammation of the kidney Semin. Nephrol. 2010, 30, 234-254
9. Moore, K. J.; Tabas, I. Macrophages in the pathogenesis of atherosclerosis Cell 2011, 145, 341-355
10. Yadav, V. R.; Prasad, S.; Sung, B.; Aggarwal, B. B. The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer Int. Immunopharmacol. 2011, 11, 295-309
11. Bashir, R.; Ovais, S.; Yaseen, S.; Hamid, H.; Alam, M. S.; Samim, M.; Singh, S.; Javed, K. Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents Bioorg. Med. Chem. Lett. 2011, 21, 4301-4305
12. Kumar, V.; Kumar, S.; Hassan, M.; Wu, H.; Thimmulappa, R. K.; Kumar, A.; Sharma, S. K.; Parmar, V. S.; Biswal, S.; Malhotra, S. V. Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells J. Med. Chem. 2011, 54, 4147-4159
13. Srinivasan, B.; Johnson, T. E.; Lad, R.; Xing, C. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3′,4′, 5′-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities J. Med. Chem. 2009, 52, 7228-7235
14. Bharate, S. B.; Mahajan, T. R.; Gole, Y. R.; Nambiar, M.; Matan, T. T.; Kulkarni-Almeida, A.; Balachandran, S.; Junjappa, H.; Balakrishnan, A.; Vishwakarma, R. A. Synthesis and evaluation of pyrazolo[3,4- b ]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors Bioorg. Med. Chem. 2008, 16, 7167-7176
15. Lorenzo, P.; Alvarez, R.; Ortiz, M. A.; Alvarez, S.; Piedrafita, F. J.; de Lera, A. R. Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids J. Med. Chem. 2008, 51, 5431-5440
16. Rao, Y. K.; Fang, S. H.; Tzeng, Y. M. Synthesis and biological evaluation of 3′,4′,5′-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation Bioorg. Med. Chem. 2009, 17, 7909-7914
17. Meng, C. Q.; Ni, L.; Worsencroft, K. J.; Ye, Z.; Weingarten, M. D.; Simpson, J. E.; Skudlarek, J. W.; Marino, E. M.; Suen, K. L.; Kunsch, C.; Souder, A.; Howard, R. B.; Sundell, C. L.; Wasserman, M. A.; Sikorski, J. A. Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases J. Med. Chem. 2007, 50, 1304-1315
18. Bandgar, B. P.; Patil, S. A.; Gacche, R. N.; Korbad, B. L.; Hote, B. S.; Kinkar, S. N.; Jalde, S. S. Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents Bioorg. Med. Chem. Lett. 2010, 20, 730-733
19. Bandgar, B. P.; Patil, S. A.; Korbad, B. L.; Nile, S. H.; Khobragade, C. N. Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity Eur. J. Med. Chem. 2010, 45, 2629-2633
20. Consonni, V.; Todeschini, R.; Pavan, M. Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 1. Theory of the novel 3D molecular descriptors J. Chem. Inf. Comput. Sci. 2002, 42, 682-692
21. Gasteiger, J.; Sadowski, J.; Schuur, J.; Selzer, P.; Steinhauer, L.; Steinhauer, V. Chemical information in 3D space J. Chem. Inf. Comput. Sci. 1996, 36, 1030-1037
22. Todeschini, R.; Consonni, V. Handbook of Molecular Descriptors, 1 st ed.; Wiley-VCH: Mannheim, Germany, 2000.
23. Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases Blood 2011, 117, 3720-3732
24. White, M.; Mahon, V.; Grealy, R.; Doherty, D. G.; Stordeur, P.; Kelleher, D. K.; McManus, R.; Ryan, T. Post operative infection and sepsis in humans is associated with deficient gene expression of gammac cytokines and their apoptosis mediators Crit Care 2011, 15, R158
25. Li, C. Y.; Chao, L. K.; Wang, S. C.; Chang, H. Z.; Tsai, M. L.; Fang, S. H.; Liao, P. C.; Ho, C. L.; Chen, S. T.; Cheng, W. C.; Chiang, C. S.; Kuo, Y. H.; Hua, K. F.; Hsu, I. C. Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells J. Cell. Physiol. 2011, 226, 2338-2349
26. Hiransai, P.; Ratanachaiyavong, S.; Itharat, A.; Graidist, P.; Ruengrairatanaroj, P.; Purintrapiban, J. Dioscorealide B suppresses LPS-induced nitric oxide production and inflammatory cytokine expression in RAW 264.7 macrophages: the inhibition of NF-kappaB and ERK1/2 activation J. Cell. Biochem. 2010, 109, 1057-1063
27. Furusawa, J.; Funakoshi-Tago, M.; Tago, K.; Mashino, T.; Inoue, H.; Sonoda, Y.; Kasahara, T. Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-kappaB p65 phosphorylation at serine 276 Cell. Signalling 2009, 21, 778-785
28. Guha, M.; Mackman, N. LPS induction of gene expression in human monocytes Cell. Signalling 2001, 13, 85-94
29. Lee, Y. J.; Kang, D. G.; Kim, J. S.; Lee, H. S. Effect of Buddleja officinalis on high-glucose-induced vascular inflammation in human umbilical vein endothelial cells Exp. Biol. Med. (Maywood, NJ, U. S.) 2008, 233, 694-700
30. Stan, D.; Calin, M.; Manduteanu, I.; Pirvulescu, M.; Gan, A. M.; Butoi, E. D.; Simion, V.; Simionescu, M. High glucose induces enhanced expression of resistin in human U937 monocyte-like cell line by MAPK- and NF-kB-dependent mechanisms; the modulating effect of insulin Cell Tissue Res. 2010, 343, 379-387
31. Voilley, N. Acid-sensing ion channels (ASICs): new targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs) Curr. Drug Targets: Inflammation Allergy 2004, 3, 71-79
32. Choi, J. M.; Yoon, B. S.; Lee, S. K.; Hwang, J. K.; Ryang, R. Antioxidant properties of neohesperidin dihydrochalcone: inhibition of hypochlorous acid-induced DNA strand breakage, protein degradation, and cell death Biol. Pharm. Bull. 2007, 30, 324-330
33. Nabi, G.; Liu, Z. Q. Radical-scavenging properties of ferrocenyl chalcones Bioorg. Med. Chem. Lett. 2011, 21, 944-946
34. Barona, I.; Fagundes, D. S.; Gonzalo, S.; Grasa, L.; Arruebo, M. P.; Plaza, M. A.; Murillo, M. D. Role of TLR4 and MAPK in the local effect of LPS on intestinal contractility J. Pharm. Pharmacol. 2011, 63, 657-662
35. Han, J. M.; Jin, Y. Y.; Kim, H. Y.; Park, K. H.; Lee, W. S.; Jeong, T. S. Lavandulyl flavonoids from Sophora flavescens suppress lipopolysaccharide- induced activation of nuclear factor-kappaB and mitogen-activated protein kinases in RAW264.7 cells Biol. Pharm. Bull. 2010, 33, 1019-1023
36. Shim, J. S.; Kwon, Y. Y.; Han, Y. S.; Hwang, J. K. Inhibitory effect of panduratin A on UV-induced activation of mitogen-activated protein kinases (MAPKs) in dermal fibroblast cells Planta Med. 2008, 74, 1446-1450
37. Kim, Y. J.; Ko, H.; Park, J. S.; Han, I. H.; Amor, E. C.; Lee, J. W.; Yang, H. O. Dimethyl cardamonin inhibits lipopolysaccharide-induced inflammatory factors through blocking NF-kappaB p65 activation Int. Immunopharmacol. 2010, 10, 1127-1134
38. Rittirsch, D.; Flierl, M. A.; Day, D. E.; Nadeau, B. A.; McGuire, S. R.; Hoesel, L. M.; Ipaktchi, K.; Zetoune, F. S.; Sarma, J. V.; Leng, L.; Huber-Lang, M. S.; Neff, T. A.; Bucala, R.; Ward, P. A. Acute lung injury induced by lipopolysaccharide is independent of complement activation J. Immunol. 2008, 180, 7664-7672
39. Soriano, F. G.; Lorigados, C. B.; Pacher, P.; Szabo, C. Effects of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis Shock 2011, 35, 560-566
40. Yozai, K.; Shikata, K.; Sasaki, M.; Tone, A.; Ohga, S.; Usui, H.; Okada, S.; Wada, J.; Nagase, R.; Ogawa, D.; Shikata, Y.; Makino, H. Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions J. Am. Soc. Nephrol. 2005, 16, 3326-3338
41. Navarro-Gonzalez, J. F.; Mora-Fernandez, C. The role of inflammatory cytokines in diabetic nephropathy J. Am. Soc. Nephrol. 2008, 19, 433-442